SCHD // Schwab U.S. Dividend Equity ETF
ANR <GO> NYSE ETF / Index • High-Quality Dividend Compounders • SIC 6726
$35.78 ▲ +0.17
(+0.48%)
MKT CAP: $65.00B • VOL: 27.72M
52W L $26 52W H $36
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$30
MEDIAN
$40
MEAN
$41
HIGH
$49
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE SCHD TAPE
SCHD // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $43.29 | $41.15 | 2025-02-14 | $32.56 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $45.08 | $42.22 | 2025-02-06 | $33.63 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $40.79 | $39.36 | 2025-01-29 | $34.35 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $36.50 | — | 2025-01-17 | $35.06 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $31.49 | $33.99 | 2025-01-09 | $31.84 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $42.58 | $37.21 | 2024-12-18 | $31.13 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $34.71 | $36.14 | 2024-12-04 | $33.28 | -4.3% | 48% | C |